Skip to main content
SpringerLink
Log in

Influence of Ketanserin on Glucose and Lipid Metabolism in Diabetic Patients with Hypertension

  • Short Communication
  • Poster Presentations: Clinical Pharmacology
  • Published:
Drugs Aims and scope Submit manuscript

Conclusion

On the basis of our results, and with regard to well-documented improvement of microcirculatory disturbances (De Clerck & David 1981; Östergren et al. 1986; Schneider et al. 1985), ketanserin should be considered as an alternative to established therapy for the treatment of hypertension in patients with concomitant diabetes mellitus.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  • Bengtsson C, Blohmè G, Lapidus L, Lindquist O, Lundgren H, et al. Do antihypertensive drugs precipitate diabetes? British Medical Journal 289: 1495–1497, 1984

    Article  CAS  PubMed  Google Scholar 

  • De Clerck F, David JL. Pharmacological control of platelets and red blood cell function in the microcirculation. Cardiovascular Pharmacology 3: 1388–1412, 1981

    Article  Google Scholar 

  • Garcia MS, McNamara PM, Gordon T, Kannel WB. Morbidity and mortality in diabetics in the Framingham population. Sixteen year follow-up study. Diabetes 23: 105–111, 1974

    CAS  PubMed  Google Scholar 

  • Östergren J, Fagrell B, Lins PE, Tooke J. The acute effect of ketanserin on skin microvascular blood flow in patients with diabetic angiography. In Maurer et al. (Eds) What is new in angiology? Trends and controversies, pp. 551–552, W. Zuckschwerdt Verlag, Munich, 1986

    Google Scholar 

  • Pell S, D’Alonzo CA. Some aspects of hypertension in diabetes mellitus. Journal of the American Medical Association 202: 104–110, 1967

    Article  CAS  PubMed  Google Scholar 

  • Raptis S. Hypertension and diabetes. In Arterial hypertension 9, pp. 93–99, Springer Verlag, New York, 1982

    Chapter  Google Scholar 

  • Rosendorff C, Murray GD. Ketanserin versus metoprolol and hydrochlorothiazide in essential hypertension: only ketanserin’s hypotensive effect is age-related. Journal of Hypertension 4(Suppl. 6): 109–111, 1986

    Google Scholar 

  • Schneider SH, Tendler M, Apelian A, Jageneau AHM, Khachadurian AK. Effects of ketanserin, a 5-HT2 receptor antagonist, on the blood flow response to temperature changes in the diabetic foot. Journal of Clinical Pharmacology 25: 413–417, 1985

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Städtisches Krankenhaus, Munich, Federal Republic of Germany

    H. U. Janka & H. Mehnert

  2. Janssen Research Foundation, Neuss, Federal Republic of Germany

    R. Fisher & K. -U. Seiler

Authors
  1. H. U. Janka
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. H. Mehnert
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. R. Fisher
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. K. -U. Seiler
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Janka, H.U., Mehnert, H., Fisher, R. et al. Influence of Ketanserin on Glucose and Lipid Metabolism in Diabetic Patients with Hypertension. Drugs 36 (Suppl 1), 123–125 (1988). https://doi.org/10.2165/00003495-198800361-00024

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00003495-198800361-00024

Keywords

Search

Navigation